Exact Mass: 567.2515
Exact Mass Matches: 567.2515
Found 500 metabolites which its exact mass value is equals to given mass value 567.2515
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
[4-((1Z)-2-(Acetylamino)-3-{[1-(1,1'-biphenyl-4-ylmethyl)-2-oxoazepan-3-YL]amino}-3-oxoprop-1-enyl)-2-formylphenyl]acetic acid
4-[[4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]-2,3-dimethylbenzoyl]-methylamino]-5-methoxy-2,2,3,3,4-pentamethyl-5-oxopentanoic acid
GalNAcGlcNAcThrNAc
[Chemical] Source; sea squirt H-antigen (limited periodate oxide)
N-(2,5,12-dimethoxy-3,11,16-trimethyl-1,4,10,13-tetraoxo-1,5,6,7,9,10,13,14,14a,15-decahydro-4H-6,15-epiazano-benzo[4,5]azocino[1,2-b]isoquinolin-9-ylmethyl)-2-oxo-propionamide|Saframycin C
3,5-bis(3-methyl-2-butenyl)-4-O-[beta-D-glucopyranosyl-(1?2)-alpha-L-arabinopyranosyl]benzamide
(6R,8E,13E,15E)-17t-acetoxy-6r-isopropyl-7c,15-dimethyl-34,5-dihydro-5-oxa-11-aza-1(4,2)-oxazola-3(1,2)-pyrrola-cycloeicosaphane-8,13,15-triene-2,4,10,19-tetraone|O14-acetyl-virginiamycin-M1|Pristinamycin II A- acetat
Arg Tyr Thr Glu
Ala Glu Trp Tyr
Ala Glu Tyr Trp
Ala Trp Glu Tyr
Ala Trp Tyr Glu
Ala Tyr Glu Trp
Ala Tyr Trp Glu
Cys Phe Ile Trp
Cys Phe Leu Trp
Cys Phe Trp Ile
Cys Phe Trp Leu
Cys Ile Phe Trp
Cys Ile Trp Phe
Cys Leu Phe Trp
Cys Leu Trp Phe
Cys Pro Trp Tyr
Cys Pro Tyr Trp
Cys Trp Phe Ile
Cys Trp Phe Leu
Cys Trp Ile Phe
Cys Trp Leu Phe
Cys Trp Pro Tyr
Cys Trp Tyr Pro
Cys Tyr Pro Trp
Cys Tyr Trp Pro
Asp Asp Arg Tyr
Asp Asp Tyr Arg
Asp Phe Met Arg
Asp Phe Arg Met
Asp Phe Thr Trp
Asp Phe Trp Thr
Asp Met Phe Arg
Asp Met Arg Phe
Asp Arg Asp Tyr
Asp Arg Phe Met
Asp Arg Met Phe
Asp Arg Tyr Asp
Asp Thr Phe Trp
Asp Thr Trp Phe
Asp Trp Phe Thr
Asp Trp Thr Phe
Asp Tyr Asp Arg
Asp Tyr Arg Asp
Glu Ala Trp Tyr
Glu Ala Tyr Trp
Glu Glu Lys Tyr
Glu Glu Gln Tyr
Glu Glu Tyr Lys
Glu Glu Tyr Gln
Glu Phe Ser Trp
Glu Phe Trp Ser
Glu His Pro Trp
Glu His Trp Pro
Glu Lys Glu Tyr
Glu Lys Tyr Glu
Glu Pro His Trp
Glu Pro Trp His
Glu Gln Glu Tyr
Glu Gln Tyr Glu
Glu Arg Thr Tyr
Glu Arg Tyr Thr
Glu Ser Phe Trp
Glu Ser Trp Phe
Glu Thr Arg Tyr
Glu Thr Tyr Arg
Glu Trp Ala Tyr
Glu Trp Phe Ser
Glu Trp His Pro
Glu Trp Pro His
Glu Trp Ser Phe
Glu Trp Tyr Ala
Glu Tyr Ala Trp
Glu Tyr Glu Lys
Glu Tyr Glu Gln
Glu Tyr Lys Glu
Glu Tyr Gln Glu
Glu Tyr Arg Thr
Glu Tyr Thr Arg
Glu Tyr Trp Ala
Phe Cys Ile Trp
Phe Cys Leu Trp
Phe Cys Trp Ile
Phe Cys Trp Leu
Phe Asp Met Arg
Phe Asp Arg Met
Phe Asp Thr Trp
Phe Asp Trp Thr
Phe Glu Ser Trp
Phe Glu Trp Ser
Phe His His Lys
Phe His His Gln
Phe His Lys His
Phe His Gln His
Phe Ile Cys Trp
Phe Ile Trp Cys
Phe Lys His His
Phe Leu Cys Trp
Phe Leu Trp Cys
Phe Met Asp Arg
Phe Met Arg Asp
Phe Gln His His
Phe Arg Asp Met
Phe Arg Met Asp
Phe Ser Glu Trp
Phe Ser Trp Glu
Phe Thr Asp Trp
Phe Thr Trp Asp
Phe Trp Cys Ile
Phe Trp Cys Leu
Phe Trp Asp Thr
Phe Trp Glu Ser
Phe Trp Ile Cys
Phe Trp Leu Cys
Phe Trp Ser Glu
Phe Trp Thr Asp
His Glu Pro Trp
His Glu Trp Pro
His Phe His Lys
His Phe His Gln
His Phe Lys His
His Phe Gln His
His His Phe Lys
His His Phe Gln
His His Lys Phe
His His Gln Phe
His Lys Phe His
His Lys His Phe
His Pro Glu Trp
His Pro Trp Glu
His Gln Phe His
His Gln His Phe
His Gln Gln Arg
His Gln Arg Gln
His Arg Gln Gln
His Trp Glu Pro
His Trp Pro Glu
Ile Cys Phe Trp
Ile Cys Trp Phe
Ile Phe Cys Trp
Ile Phe Trp Cys
Ile Ser Trp Tyr
Ile Ser Tyr Trp
Ile Trp Cys Phe
Ile Trp Phe Cys
Ile Trp Ser Tyr
Ile Trp Tyr Ser
Ile Tyr Ser Trp
Ile Tyr Trp Ser
Lys Glu Glu Tyr
Lys Glu Tyr Glu
Lys Phe His His
Lys His Phe His
Lys His His Phe
Lys Tyr Glu Glu
Leu Cys Phe Trp
Leu Cys Trp Phe
Leu Phe Cys Trp
Leu Phe Trp Cys
Leu Ser Trp Tyr
Leu Ser Tyr Trp
Leu Trp Cys Phe
Leu Trp Phe Cys
Leu Trp Ser Tyr
Leu Trp Tyr Ser
Leu Tyr Ser Trp
Leu Tyr Trp Ser
Met Asp Phe Arg
Met Asp Arg Phe
Met Phe Asp Arg
Met Phe Arg Asp
Met Met Met Arg
Met Met Arg Met
Met Met Thr Trp
Met Met Trp Thr
Met Arg Asp Phe
Met Arg Phe Asp
Met Arg Met Met
Met Arg Val Tyr
Met Arg Tyr Val
Met Thr Met Trp
Met Thr Trp Met
Met Val Arg Tyr
Met Val Tyr Arg
Met Trp Met Thr
Met Trp Thr Met
Met Tyr Arg Val
Met Tyr Val Arg
Pro Cys Trp Tyr
Pro Cys Tyr Trp
Pro Glu His Trp
Pro Glu Trp His
Pro His Glu Trp
Pro His Trp Glu
Pro Trp Cys Tyr
Pro Trp Glu His
Pro Trp His Glu
Pro Trp Tyr Cys
Pro Tyr Cys Trp
Pro Tyr Trp Cys
Gln Glu Glu Tyr
Gln Glu Tyr Glu
Gln Phe His His
Gln His Phe His
Gln His His Phe
Gln His Gln Arg
Gln His Arg Gln
Gln Gln His Arg
Gln Gln Arg His
Gln Arg His Gln
Gln Arg Gln His
Gln Tyr Glu Glu
Arg Asp Asp Tyr
Arg Asp Phe Met
Arg Asp Met Phe
Arg Asp Tyr Asp
Arg Glu Thr Tyr
Arg Glu Tyr Thr
Arg Phe Asp Met
Arg Phe Met Asp
Arg His Gln Gln
Arg Met Asp Phe
Arg Met Phe Asp
Arg Met Met Met
Arg Met Val Tyr
Arg Met Tyr Val
Arg Gln His Gln
Arg Gln Gln His
Arg Thr Glu Tyr
Arg Thr Tyr Glu
Arg Val Met Tyr
Arg Val Tyr Met
Arg Tyr Asp Asp
Arg Tyr Glu Thr
Arg Tyr Met Val
Arg Tyr Val Met
Ser Glu Phe Trp
Ser Glu Trp Phe
Ser Phe Glu Trp
Ser Phe Trp Glu
Ser Ile Trp Tyr
Ser Ile Tyr Trp
Ser Leu Trp Tyr
Ser Leu Tyr Trp
Ser Trp Glu Phe
Ser Trp Phe Glu
Ser Trp Ile Tyr
Ser Trp Leu Tyr
Ser Trp Tyr Ile
Ser Trp Tyr Leu
Ser Tyr Ile Trp
Ser Tyr Leu Trp
Ser Tyr Trp Ile
Ser Tyr Trp Leu
Thr Asp Phe Trp
Thr Asp Trp Phe
Thr Glu Arg Tyr
Thr Glu Tyr Arg
Thr Phe Asp Trp
Thr Phe Trp Asp
Thr Met Met Trp
Thr Met Trp Met
Thr Arg Glu Tyr
Thr Arg Tyr Glu
Thr Val Trp Tyr
Thr Val Tyr Trp
Thr Trp Asp Phe
Thr Trp Phe Asp
Thr Trp Met Met
Thr Trp Val Tyr
Thr Trp Tyr Val
Thr Tyr Glu Arg
Thr Tyr Arg Glu
Thr Tyr Val Trp
Thr Tyr Trp Val
Val Met Arg Tyr
Val Met Tyr Arg
Val Arg Met Tyr
Val Arg Tyr Met
Val Thr Trp Tyr
Val Thr Tyr Trp
Val Trp Thr Tyr
Val Trp Tyr Thr
Val Tyr Met Arg
Val Tyr Arg Met
Val Tyr Thr Trp
Val Tyr Trp Thr
Trp Ala Glu Tyr
Trp Ala Tyr Glu
Trp Cys Phe Ile
Trp Cys Phe Leu
Trp Cys Ile Phe
Trp Cys Leu Phe
Trp Cys Pro Tyr
Trp Cys Tyr Pro
Trp Asp Phe Thr
Trp Asp Thr Phe
Trp Glu Ala Tyr
Trp Glu Phe Ser
Trp Glu His Pro
Trp Glu Pro His
Trp Glu Ser Phe
Trp Glu Tyr Ala
Trp Phe Cys Ile
Trp Phe Cys Leu
Trp Phe Asp Thr
Trp Phe Glu Ser
Trp Phe Ile Cys
Trp Phe Leu Cys
Trp Phe Ser Glu
Trp Phe Thr Asp
Trp His Glu Pro
Trp His Pro Glu
Trp Ile Cys Phe
Trp Ile Phe Cys
Trp Ile Ser Tyr
Trp Ile Tyr Ser
Trp Leu Cys Phe
Trp Leu Phe Cys
Trp Leu Ser Tyr
Trp Leu Tyr Ser
Trp Met Met Thr
Trp Met Thr Met
Trp Pro Cys Tyr
Trp Pro Glu His
Trp Pro His Glu
Trp Pro Tyr Cys
Trp Ser Glu Phe
Trp Ser Phe Glu
Trp Ser Ile Tyr
Trp Ser Leu Tyr
Trp Ser Tyr Ile
Trp Ser Tyr Leu
Trp Thr Asp Phe
Trp Thr Phe Asp
Trp Thr Met Met
Trp Thr Val Tyr
Trp Thr Tyr Val
Trp Val Thr Tyr
Trp Val Tyr Thr
Trp Tyr Ala Glu
Trp Tyr Cys Pro
Trp Tyr Glu Ala
Trp Tyr Ile Ser
Trp Tyr Leu Ser
Trp Tyr Pro Cys
Trp Tyr Ser Ile
Trp Tyr Ser Leu
Trp Tyr Thr Val
Trp Tyr Val Thr
Tyr Ala Glu Trp
Tyr Ala Trp Glu
Tyr Cys Pro Trp
Tyr Cys Trp Pro
Tyr Asp Asp Arg
Tyr Asp Arg Asp
Tyr Glu Ala Trp
Tyr Glu Glu Lys
Tyr Glu Glu Gln
Tyr Glu Lys Glu
Tyr Glu Gln Glu
Tyr Glu Arg Thr
Tyr Glu Thr Arg
Tyr Glu Trp Ala
Tyr Ile Ser Trp
Tyr Ile Trp Ser
Tyr Lys Glu Glu
Tyr Leu Ser Trp
Tyr Leu Trp Ser
Tyr Met Arg Val
Tyr Met Val Arg
Tyr Pro Cys Trp
Tyr Pro Trp Cys
Tyr Gln Glu Glu
Tyr Arg Asp Asp
Tyr Arg Glu Thr
Tyr Arg Met Val
Tyr Arg Thr Glu
Tyr Arg Val Met
Tyr Ser Ile Trp
Tyr Ser Leu Trp
Tyr Ser Trp Ile
Tyr Ser Trp Leu
Tyr Thr Glu Arg
Tyr Thr Arg Glu
Tyr Thr Val Trp
Tyr Thr Trp Val
Tyr Val Met Arg
Tyr Val Arg Met
Tyr Val Thr Trp
Tyr Val Trp Thr
Tyr Trp Ala Glu
Tyr Trp Cys Pro
Tyr Trp Glu Ala
Tyr Trp Ile Ser
Tyr Trp Leu Ser
Tyr Trp Pro Cys
Tyr Trp Ser Ile
Tyr Trp Ser Leu
Tyr Trp Thr Val
Tyr Trp Val Thr
5-DMT-N6-Me-2-dA
5'-O-DMT-N6-Me-2'-dA is a nucleoside with protective and modification effects.
azepan-2-one,1,3-diisocyanato-2-methylbenzene,2,4-diisocyanato-1-methylbenzene,2-(2-hydroxyethoxy)ethanol
Mibefradil dihydrochloride
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
(alphaS)-alpha-Aminobenzenebutanoyl-L-leucyl-L-phenylalanine methyl ester mono(trifluoroacetate)
HG-9-91-01
Phenyl 3-azido-3-deoxy-2,4,6-tris-O-(phenylmethyl)-1-thio-beta-D-glucopyranoside
(11bR)-2,6-Bis(3,5-dimethylphenyl)-N,N-dimethyl-dinaphtho[2,1-d:1,2-f][1,3,2]dioxaphosphepin-4-amine
Phenyl 4-azido-4-deoxy-2,3,6-tris-O-(phenylmethyl)-1-thio-beta-D-glucopyranoside
(S)-2-((9-([1,1-biphenyl]-4-ylmethyl)-2-((2,3-dihydro-1H-inden-5-yl)oxy)-9H-purin-6-yl)amino)-3-phenylpropan-1-ol
3-[[(2R)-2-hydroxypropyl]amino]-3-methyl-N-[(3R)-2-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-4,5-dihydro-3H-1-benzazepin-3-yl]butanamide
[4-((1Z)-2-(Acetylamino)-3-{[1-(1,1-biphenyl-4-ylmethyl)-2-oxoazepan-3-YL]amino}-3-oxoprop-1-enyl)-2-formylphenyl]acetic acid
2-[4-[(Z)-2-acetamido-3-oxo-3-[[2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid
N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
1-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
(1S)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-[(5-phenyl-3-isoxazolyl)methyl]-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
(2R,3S)-8-(2-benzofuranyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
3-methoxy-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
(1R)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-[(5-phenyl-3-isoxazolyl)methyl]-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(5,9-Diacetyloxy-2,6,10-trimethyl-16-oxo-14-pyridin-3-yl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-12(17),13-dien-6-yl)methyl acetate
(E)-N-[2-[2-[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-3,4-dihydroxy-3,4-dihydro-2H-pyran-5-yl]dodec-2-enamide
N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydec-4-en-2-yl]propanamide
N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyundec-4-en-2-yl]acetamide
N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]pentanamide
N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynon-4-en-2-yl]butanamide
N-[(2S,3R,4R,5R,6R)-2-[(2S,3R,4S,5S,6R)-5-acetamido-6-[(2S,3R)-3-acetamido-4-hydroxy-1-oxobutan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
GDC-6036-NH
GDC-6036-NH is from patent WO2020097537A2, and a precursor of compound 17 a/b. Compound 17 a/b is a RAS inhibitor and can be used in cancer research[1].
15-veratroyl-17-acetyl-19-oxodictizine
{"Ingredient_id": "HBIN001727","Ingredient_name": "15-veratroyl-17-acetyl-19-oxodictizine","Alias": "NA","Ingredient_formula": "C32H41NO8","Ingredient_Smile": "CC(=O)OCC1(C2CCC3(C1OC(=O)C4=CC(=C(C=C4)OC)OC)C5CC6C7(CCCC6(C3C2)C5N(C7=O)C)C)O","Ingredient_weight": "567.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "22375","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21579305","DrugBank_id": "NA"}